Vivo Capital, LLC Q2 2019 Filing
Filed August 13, 2019
Portfolio Value
$1.1T
Holdings
46
Report Date
Q2 2019
Filing Type
13F-HR
All Holdings (46 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDAscendis Pharma A/S | 2,060,135 | $237.2B | 22.23% | |
| 2 | CRNXCrinetics Pharmaceuticals Inc | 3,375,169 | $84.4B | 7.91% | |
| 3 | ARWRArrowhead Pharmaceuticals Inc | 2,765,153 | $73.3B | 6.87% | |
| 4 | 1T7Tricida, Inc. | 1,424,525 | $56.2B | 5.27% | |
| 5 | CDXSCodexis, Inc | 2,614,458 | $48.2B | 4.52% | |
| 6 | IM8NInsmed Inc | 1,748,174 | $44.8B | 4.19% | |
| 7 | IOVAIovance Biotherapeutics, Inc. | 1,600,000 | $39.2B | 3.68% | |
| 8 | SVASinovac Biotech Ltd. | 5,900,000 | $38.2B | 3.58% | |
| 9 | —Zymeworks Inc | 1,453,467 | $32.0B | 3.00% | |
| 10 | KALVKalVista Pharmaceuticals Inc. | 1,359,149 | $30.1B | 2.82% | |
| 11 | —Kadmon Holdings Inc | 12,606,605 | $26.0B | 2.43% | |
| 12 | —The Medicines Company | 669,012 | $24.4B | 2.29% | |
| 13 | —Menlo Therapeutics Inc. | 4,011,236 | $24.0B | 2.25% | |
| 14 | MRTXEURMirati Therapeutics Inc. | 233,045 | $24.0B | 2.25% | |
| 15 | AMRSEURAmyris, Inc | 6,490,557 | $23.1B | 2.17% | |
| 16 | FIXXEURHomology Medicines, Inc. | 1,159,742 | $22.7B | 2.13% | |
| 17 | CLDNEUREiger BioPharmaceuticals Inc | 1,791,257 | $19.0B | 1.78% | |
| 18 | ORTXUSDOrchard Therapeutics plc | 1,312,084 | $18.4B | 1.72% | |
| 19 | —Chiasma Inc | 2,377,213 | $17.8B | 1.66% | |
| 20 | CBAYUSDCymabay Therapeutics Inc | 2,154,934 | $15.4B | 1.45% | |
| 21 | MEIPUSDMEI Pharma Inc | 5,681,397 | $14.2B | 1.33% | |
| 22 | XENEXenon Pharmaceuticals Inc | 1,405,476 | $13.9B | 1.30% | |
| 23 | AUPHAurinia Pharmaceuticals Inc. | 1,913,623 | $12.6B | 1.18% | |
| 24 | —Soleno Therapeutics, Inc. | 4,268,959 | $12.0B | 1.12% | |
| 25 | RCKTRocket Pharmaceuticals Inc | 786,712 | $11.8B | 1.11% | |
| 26 | KNSAKiniksa Pharmaceuticals | 843,478 | $11.4B | 1.07% | |
| 27 | —Obseva SA | 937,147 | $10.6B | 0.99% | |
| 28 | —Nabriva Therapeutics AG | 4,039,139 | $9.8B | 0.92% | |
| 29 | APLSApellis Pharmaceuticals, Inc. | 383,538 | $9.7B | 0.91% | |
| 30 | VRNAVerona Pharma PLC | 1,492,951 | $7.6B | 0.71% | |
| 31 | GLMDGalmed Pharmaceuticals Ltd | 971,337 | $7.1B | 0.67% | |
| 32 | —Dermira Inc | 700,000 | $6.7B | 0.63% | |
| 33 | KALAKala Pharmaceuticals, Inc. | 1,043,020 | $6.7B | 0.62% | |
| 34 | KRTXKaruna Therapeutics Inc | 325,000 | $6.5B | 0.61% | |
| 35 | MTNBEURMatinas Biopharma Hldgs Inc | 6,818,181 | $5.8B | 0.55% | |
| 36 | —Zogenix Inc | 105,000 | $5.0B | 0.47% | |
| 37 | DTILPrecision Biosciences Inc | 280,511 | $3.7B | 0.35% | |
| 38 | ACRSAclaris Therapeutics, Inc. | 1,647,214 | $3.6B | 0.34% | |
| 39 | GNCAQGenocea Biosciences Inc | 626,401 | $2.5B | 0.23% | |
| 40 | —DBV Technologies S.A. | 269,995 | $2.2B | 0.21% | |
| 41 | —Agile Therapeutics, Inc. | 1,513,975 | $2.2B | 0.21% | |
| 42 | —Sierra Oncology, Inc | 2,438,270 | $1.4B | 0.13% | |
| 43 | SELBUSDSelecta Biosciences Inc | 546,054 | $977.0M | 0.09% | |
| 44 | —Akari Therapeutics Plc | 345,850 | $699.0M | 0.07% | |
| 45 | —BioPharmX Corporation | 317,270 | $189.0M | 0.02% | |
| 46 | —Soleno Therapeutics, Inc. - Warrant | 188,772 | $19.0M | 0.00% |